跳至主要内容
临床试验/NCT06731400
NCT06731400尚未招募不适用

Variability in Human Fatty Acids Profiles Based on Blood Fractions and Metabolic Conditions

University of Sao Paulo0 个研究点目标入组 6 人开始时间: 2024年12月3日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
6
主要终点
The fasting or postprandial states on the fatty acid profile

研究概览

简要总结

Fatty acids play a crucial role in various metabolic pathways, with their proportions and distributions across different cells and tissues influenced by diet and metabolism. In addition to providing energy through oxidative reactions, fatty acids serve as substrates for the synthesis of numerous molecules involved in cellular signaling processes. Therefore, quantifying fatty acids in biological samples is essential for ensuring the quality of clinical trials involving lipids and for understanding the relationship between fats and health conditions. However, the fatty acid profiles reported in clinical trials can exhibit significant heterogeneity due to both endogenous and exogenous factors, including the metabolic condition of the patients and the specific blood fraction analyzed. This variability makes difficult the comparison of results across studies. Moreover, despite the crucial role of fatty acids in immune response, most results are derived from erythrocytes, plasma, or serum, providing limited information on their variability in leukocytes. Thus, the hypothesis of this study is that metabolic conditions, characterized by fasting or postprandial states, can influence the fatty acid profile depending on the blood fraction analyzed. To evaluate this hypothesis, six healthy individuals will be supplemented with fish oil for eight weeks, with blood samples collected before and after the intervention. Fatty acid levels will be measured using gas chromatography coupled with mass spectrometry in total plasma, phospholipids, erythrocytes, and leukocytes. The results will help estimate the variability caused by metabolic states according to the blood fraction, which is critical when conducting clinical trials in patients where fasting cannot be assured and is essential for comparing fatty acid profiles in studies involving leukocytes.

详细描述

In summary, it is known that numerous factors can interfere with the effects of administering polyunsaturated fatty acids (n-3 PUFA), including aspects related to the experimental design, such as the form and dosage used, the duration of treatments, the blood fraction and the metabolic state of the individuals. In this context, given the importance of precise quantification of fatty acids in biological samples obtained from humans, the present study will aim to evaluate the variability caused by the administration of fish oil before and after 8 weeks of supplementation. This will involve comparing the fatty acid profiles according to different fractions (plasma, leukocytes, and erythrocytes) and fasting conditions (fasting or post-prandial). In plasma, the analysis will also consider both the total sample and the phospholipidic fraction.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Single Group
主要目的
Other
盲法
None

入排标准

年龄范围
20 Years 至 50 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Individuals of both sexes
  • Aged between 20 and 50 years
  • No contraindications for the use of fish oil supplements

排除标准

  • Use of medications or supplements to reduce triacylglycerols;
  • Consumption of fish oil or other supplements/medicines rich in n-3 or n-6 PUFA in the month before the test;
  • Consumption of fatty fish (salmon, herring, mackerel, white tuna or sardines) more than twice a month in the month before the test;
  • Refusal to avoid PUFA supplements and seafood during the study period;
  • Severe heart failure;
  • Severe active liver disease;
  • Planned coronary intervention or surgery,
  • History of acute or chronic pancreatitis;
  • Hypersensitivity to fish, shellfish or capsule ingredients;
  • Autoimmune diseases requiring immunosuppressive therapy;
  • Current corticosteroid use systemic,
  • Neoplasms;
  • Chemotherapy or radiotherapy within the past 12 months (patients who have undergone curative surgery without requiring additional treatment within the past year may be included);
  • Inflammatory bowel disease;
  • Chronic diarrhea;
  • Significant non-transient hematological abnormalities;
  • Kidney dysfunction;
  • Severe liver disease;
  • Inability to provide informed record;
  • Participation in another clinical trial with an experimental agent in the last 90 days;
  • Malabsorption syndrome;
  • Recent drug or alcohol abuse;
  • Atrial fibrillation;
  • Bleeding disorders.
  • Pregnancy
  • Breastfeeding.

结局指标

主要结局

The fasting or postprandial states on the fatty acid profile

时间窗: From December 2024 to February 2025

This study will assess whether fasting or postprandial states affect the fatty acid profile based on the blood fraction analyzed. Six healthy individuals will be supplemented with 2 g/day of fish oil for eight weeks, with blood samples collected before and after the intervention. Fatty acid levels will be measured using gas chromatography-mass spectrometry in total plasma, phospholipids, erythrocytes, and leukocytes.

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Inar Castro Erger

Professor

University of Sao Paulo

相似试验